-- Nova Leap Health (NLH.V) 旗下子公司 Earth Angels 週五宣布，已斥資 350 萬美元收購了位於新斯科細亞省的 Parkwood Home Care。 Nova Leap 在聲明中表示，該公司將以 320 萬美元現金支付，並開立為期三年、金額為 30 萬美元的本票。 交易完成時的現金支付資金來源包括 Nova Leap 收購債務融資額度中的 220 萬美元以及公司自有的 100 萬美元現金。新增債務的償還期限為五年。該公司表示，仍有高達 305 萬美元的可用信貸額度。 Parkwood 公佈的 2025 財年未經審計的收入為 380 萬美元，調整後 EBITDA 為 78.5 萬美元。 「新斯科細亞省是Nova Leap成長最快的地區，並在2025年取得了創紀錄的業績，」執行長克里斯·多賓表示。 「Earth Angels收購Parkwood是我們在熟悉的市場中進一步擴大規模的必然之舉。此次收購增強了我們高效擴張的能力，深化了我們在該省的業務，並拓展了我們在整個醫療保健服務體系中的作用，從而為我們在新斯科舍省的平台實現持續增長奠定了基礎。」 週四，Nova Leap股票在多倫多證券交易所創業板收盤價持平於0.37加幣。
Related Articles
Research
Research Alert: CFRA Retains Sell Opinion On Shares Of Camden Property Trust
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target by $6 to $94 using a forward P/FFO of 14.4x, compared to the multi-family residential REIT peer average of 15.5x. We lowered our 2026 FFO estimate by $0.05 to $6.65 and reduce 2027's by $0.20 to 6.855 per share, on projected revenue of $1.56B and $1.60B, or 2.5% Y/Y revenue growth. Management expects 2026 FFO to be in the range of $6.60 to $6.90 with a midpoint of $6.75, representing a $0.13 per share decrease from 2025 results. This decrease is anticipated to result primarily from a decrease in fee and asset management income and a significant increase in operating expenses. CPT is looking to sell rental communities in CA given regulation that limits ROI. The expected sales is projected to bring in $1.1B of capital into the Sunbelt markets for new property acquisitions, and share repurchases. However, we believe the Sunbelt markets have too much new supply in local markets that limits pricing power for CPT to raise rental rates on new leases and taper lease renewal rates as well.
$CPT
Research
Research Alert: Trp: Q1 Earnings Beat, Strength In Mexico
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:TRP posted Q1 adjusted EPS of CAD0.99 vs. consensus CAD0.95, beating by CAD0.02, while comparable EBITDA rose 14% to CAD3.1B and segment earnings increased 10% to CAD2.2B. All segments delivered Y/Y growth with Mexico Natural Gas Pipelines leading at 84% earnings surge to CAD389M, driven by Southeast Gateway pipeline and higher Sur de Texas equity earnings. The company announced the strategic USD1.5B Appalachia Supply Project, expanding Columbia Gas system capacity by 0.8 Bcf/d with 2030 in-service target and expected 7.3x build multiple. Management reaffirmed 2026 guidance with comparable EBITDA of CAD11.6B-CAD11.8B and capex of CAD6.0B-CAD6.5B. Net cash from operations surged 92% to CAD2.6B while comparable funds from operations rose 20% to CAD2.3B, as capital spending decreased to CAD1.3B from CAD1.8B due to major project completions. TRP achieved seven delivery records during Winter Storm Fern while maintaining best safety performance in six years.
$TRP
Research
Research Alert: CFRA Maintains Buy Opinion On Shares Of Trane Technologies
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target to $540 from $486, based on a 2027 P/E of 31.5x, a premium to the five-year average of 27.7x on promising sales and margin expansion. Following TT's Q1 beat and guidance increase, we raise our estimates and price target and reiterate our Buy rating on the shares. We increase our adjusted EPS estimates to $14.95 from $14.87 for 2026 and to $17.15 from $16.76 for 2027. TT posted Q1 adjusted EPS of $2.63 vs. $2.45 (+7%), well ahead of the $2.53 consensus. TT's Q1 sales increased 6% to $4.97B ($150M ahead of consensus), but adjusted EBIT margin contracted 20 bps to 16.0%. Organic bookings were up 24%, led by Americas Commercial HVAC, up approximately 40%. TT ended Q1 2026 with a record backlog of $10.7B, up over 30% versus year-end 2025 levels. Management raised full-year 2026 guidance, now expecting 2026 revenue growth of ~9.5% (vs 8.5%-9.5% previously) and adjusted EPS of $14.75-$14.95 (vs $14.65-$14.85 previously).
$TT